Is It Time To Reconsider Illumina (ILMN) After Mixed Multi Year Share Performance?

PharmaVoiceProtein degraders gain speed as Arvinas scores landmark approval

Endpoints NewsWindward Bio gets $165M to take China-derived drug into Phase 3 asthma trial

LabiotechNeedle-free diabetes care: 6 devices that painlessly monitor blood sugar

Thermo FisherThermo Fisher Introduces Gibco CTS DynaXS Single Use Bioreactor For Scalable Cell Therapy Manufacturing - BioPharma APAC

FierceBiotechCelcuity’s gedatolisib beats Novartis’ Piqray in phase 3 breast cancer study

FierceBiotechUCB inks $2B Candid buyout to join Gilead in autoimmune field

IlluminaIllumina Partners with Florida State University Lab for Rare Disease Genome Sequencing - Clinical Lab Products

BioPharma DiveUCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases

BioPharma DiveWhat is your AI drug repurposing strategy missing?

FierceBiotech‘Real momentum’ or ‘completely absurd’? How Trump’s support has shaken up psychedelics

Cytiva (Google News)Rockwell Automation and Cytiva join hands to accelerate digital transformation for biopharma companies - BioSpectrum Asia

Cytiva (Google News)Rockwell Automation and Cytiva Introduce Figurate SCADA: Addressing Digital Fragmentation in Biopharma Manufacturing - ARCweb.com